In vitro comparison of acyclovir, ganciclovir and cidofovir against equid alphaherpesvirus 3 and evaluation of their efficacy against six field isolates [Comparación in vitro de aciclovir, ganciclovir y cidofovir contra alfa-herpesvirus equino 3 y evaluación de la eficacia de los mismos frente a 6 aislamientos de campo del virus]
Vissani, M. A.; Zabal, O.; Tordoya, M. S.et al.
2018 • In Revista Argentina de Microbiologia, 50, p. 380-390
Vissani, M. A.; Instituto de Virología, CICVyA, INTA-Castelar, Las Cabañas y Los Reseros s/n, Castelar (1712), Buenos Aires, Argentina
Zabal, O.; Instituto de Virología, CICVyA, INTA-Castelar, Las Cabañas y Los Reseros s/n, Castelar (1712), Buenos Aires, Argentina, Cátedra de Enfermedades Infecciosas, Escuela de Veterinaria, Universidad del Salvador, Champagnat 1599, Ruta Panamericana km54.5 (B1630AHU), Pilar, Buenos Aires, Argentina
Tordoya, M. S.; Instituto de Virología, CICVyA, INTA-Castelar, Las Cabañas y Los Reseros s/n, Castelar (1712), Buenos Aires, Argentina
Parreño, V.; Instituto de Virología, CICVyA, INTA-Castelar, Las Cabañas y Los Reseros s/n, Castelar (1712), Buenos Aires, Argentina
Thiry, Etienne ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires (DMI) > Virologie vétérinaire et maladies virales animales
Barrandeguy, M.; Instituto de Virología, CICVyA, INTA-Castelar, Las Cabañas y Los Reseros s/n, Castelar (1712), Buenos Aires, Argentina, Cátedra de Enfermedades Infecciosas, Escuela de Veterinaria, Universidad del Salvador, Champagnat 1599, Ruta Panamericana km54.5 (B1630AHU), Pilar, Buenos Aires, Argentina
Language :
English
Title :
In vitro comparison of acyclovir, ganciclovir and cidofovir against equid alphaherpesvirus 3 and evaluation of their efficacy against six field isolates [Comparación in vitro de aciclovir, ganciclovir y cidofovir contra alfa-herpesvirus equino 3 y evaluación de la eficacia de los mismos frente a 6 aislamientos de campo del virus]
Publication date :
2018
Journal title :
Revista Argentina de Microbiologia
ISSN :
0325-7541
eISSN :
1851-7617
Publisher :
Asociacion Argentina de Microbiologia
Volume :
50
Pages :
380-390
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
INTA - Instituto Nacional de Tecnología Agropecuaria
Allen, G., Umphenour, W., Equine coital exanthema. Coetzer, J., Tustin, R., (eds.) Infectious diseases of livestock, 2004, Oxford Press, Cape Town, 860–867.
Anonymous, Virus taxonomy: 2016 release. 2017.
Azab, W., Tsujimura, K., Kato, K., Arii, J., Morimoto, T., Kawaguchi, Y., Tohya, Y., Matsumura, T., Akashia, H., Characterization of a thymidine kinase-deficient mutant of equine herpesvirus 4 and in vitro susceptibility of the virus to antiviral agents. Antiviral Res 85 (2010), 389–395.
Barrandeguy, M., Thiry, E., Equine coital exanthema and its potential economic implications for the equine industry. Vet J 191 (2012), 35–40.
Barrandeguy, M., Vissani, A., Olguin, C., Barbara, G., Valenzuela, H., Becerra, L., Tordoya, M., Miño, S., Thiry, E., Experimental infection with equid herpesvirus 3 in seronegative and seropositive mares. Vet Microbiol 160 (2012), 319–326.
Barrandeguy, M., Vissani, A., Olguin, C., Becerra, L., Miño, S., Pereda, A., Oriol, J., Thiry, E., Experimental reactivation of equine herpesvirus-3 following corticosteroid treatment. Equine Vet J 40 (2008), 593–595.
Barrandeguy, M., Vissani, A., Pont Lezica, F., Salamone, J., Heguy, A., Becerra, L., Olguin Perglione, C., Thiry, E., Subclinical infection and periodic shedding of equid herpesvirus 3. Theriogenology 74 (2010), 576–580.
De Clercq, E., Strategies in the design of antiviral drugs. Nat Rev Drug Discov 1 (2002), 13–25.
Cullinane, A., McGing, B., Naughton, C., The use of acyclovir in the treatment of coital exanthema and ocular disease caused by equine herpesvirus. Plowright, W., Nakajima, H., (eds.) Equine Infectious Diseases VII, 3rd ed., 1994, R & W Publications, Newmarket (Suffolk), 55.
Davison, A.J., Herpesvirus systematics. Vet Microbiol 143 (2010), 52–69.
Fontenelle, J., Powell, C., Veir, J., Radecki, S., Lappin, M., Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats. Am J Vet Res 69 (2008), 289–293.
Garré B., van der Meulen, K., Nugent, J., Neyts, J., Croubels, S., De Backer, P., Nauwynck, H., In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet. Vet Microbiol 122 (2007), 43–51.
Horzinek, M.C., Addie, D., Belák, S., Boucraut-Baralon, C., Egberink, H., Frymus, T., Gruffydd-Jones, T., Hartmann, K., Hosie, M., Lloret, A., Lutz, H., Marsilio, F., Möstl, K., Pennisi, M., Radford, A., Thiry, E., Truyen, U., ABCD Update of the 2009 guidelines on prevention and management of feline infectious diseases. J Feline Med Surg 15 (2013), 530–539.
Hussein, I.T.M., Field, H.J., Development of a quantitative real-time TaqMan PCR assay for testing the susceptibility of feline herpesvirus-1 to antiviral compounds. J Virol Methods 152 (2008), 85–90.
Maggs, D.J., Antiviral therapy for feline herpesvirus infections. Vet Clin North Am Small Anim Pract 40 (2010), 1055–1062.
van der Meulen, K., Garré B., Croubels, S., Nauwynck, H., In vitro comparison of antiviral drugs against feline herpesvirus 1. BMC Vet Res, 2, 2006, 13.
Nugent, J., Birch-Machin, I., Smith, K.C., Mumford, J.A., Swann, Z., Newton, J.R., Bowden, R.J., Allen, G.P., Davis-Poynter, N., Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. J Virol 15 (2006), 4047–4060.
Razonable, R.R., Bobmphvft, J.E.F., Tfsjof, B.O.E., Joijcjupst, Q., Therapy antiviral: antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin Proc 86 (2011), 1009–1026.
Reed, L.J., Muench, H., A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27 (1938), 493–497.
Smith, K.O., Galloway, K.S., Hodges, S.L., Ogilvie, K.K., Radatus, B.K., Kalter, S.S., Heberling, R.L., Sensitivity of equine herpesviruses 1 and 3 in vitro to a new nucleoside analogue, 9-[[2-hydroxy-1-(hydroxymethyl) ethoxy] methyl] guanine. Am J Vet Res 44 (1983), 1032–1035.
Tempesta, M., Camero, M., Bellacicco, A.L., Thiry, J., Crescenzo, G., Neyts, J., Thiry, E., Buonavoglia, C., Cidofovir is effective against caprine herpesvirus 1 infection in goats. Antiviral Res 74 (2007), 138–141.
Tempesta, M., Camero, M., Bellacicco, A.L., Tarsitano, E., Crescenzo, G., Potent inhibition of genital herpesvirus infection in goats by cidofovir. Antivir Ther 12 (2007), 977–979.
Tempesta, M., Crescenzo, G., Camero, M., Bellacicco, A.L., Tarsitano, E., Decaro, N., Neyts, J., Martella, V., Buonavoglia, C., Assessing the efficacy of cidofovir against herpesvirus-induced genital lesions in goats using different therapeutic regimens. Antimicrob Agents Chemother 52 (2008), 4064–4068.
Thi, T.N., Deback, C., Malet, I., Bonnafous, P., Ait-Arkoub, Z., Agut, H., Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR. Antiviral Res 69 (2006), 152–157.
Thiry, E., Addie, D., Belák, S., Boucraut-Baralon, C., Egberink, H., Frymus, T., Gruffydd-Jones, T., Hartmann, K., Hosie, M., Lloret, A., Lutz, H., Marsilio, F., Pennisi, M., Radford, A., Truyen, U., Horzinek, M., Feline herpesvirus infection ABCD guidelines on prevention and management. J Feline Med Surg 11 (2009), 547–555.
Vissani, M.A., Thiry, E., Dal Pozzo, F., Barrandeguy, M., Antiviral agents against equid alphaherpesviruses: current status and perspectives. Vet J 207 (2016), 38–44.
Vissani, M.A., Becerra, M.L., Olguín Perglione, C., Tordoya, M.S., Miño, S., Barrandeguy, M., Neuropathogenic and non-neuropathogenic genotypes of equid herpesvirus type 1 in Argentina. Vet Microbiol 139 (2009), 361–364.
